Provenienza dei contatti di primo grado di Greg Troiano
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Biotechnology | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Greg Troiano tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| XOMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
US Oncology, Inc.
 US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Medical/Nursing Services | Director/Board Member | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Brookside Capital Investors LP | Director/Board Member | ||
| RADIUS HEALTH, INC. | Biotechnology | Chairman | |
| DNIB UNWIND INC | Biotechnology | Chairman Corporate Officer/Principal | |
| MALIN CORPORATION PLC | Biotechnology | Director/Board Member | |
| University of Virginia | College/University | Corporate Officer/Principal Graduate Degree | |
Bain Capital LP
 Bain Capital LP Financial ConglomeratesFinance Bain Capital LP engages in provision of investment consulting services. It specializes in private equity, credit, public equity, venture, real estate, double impact, life sciences, and partnership strategies. The company was founded in 1984 and is headquartered in Boston, MA. | Financial Conglomerates | Director/Board Member | |
| Boston University | College/University | Undergraduate Degree Doctorate Degree | |
Brookside Capital, Inc.
 Brookside Capital, Inc. Investment ManagersFinance Brookside Capital, Inc. is an independent wealth management firm headquartered in San Francisco, California. The firm was founded by James Rea in 1989. They provide investment management services to high-net worth individuals and charitable organizations. | Investment Managers | Director/Board Member | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Ziff Brothers Investments LLC
 Ziff Brothers Investments LLC Investment ManagersFinance Founded in 1992, Ziff Brothers Investments LLC is a hedge fund manager located in New York City. The firm is the primary investment vehicle of the Ziff family, founders of Ziff-Davis Publishing. | Investment Managers | Corporate Officer/Principal | |
| Lehigh University | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Corporate Officer/Principal | |
| Worcester Polytechnic Institute | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
| Ghent University | College/University | Doctorate Degree | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Center for Drug Evaluation & Research | General Government | Corporate Officer/Principal | |
The United States Pharmacopeia
 The United States Pharmacopeia Pharmaceuticals: MajorHealth Technology The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD. | Pharmaceuticals: Major | Director/Board Member | |
MassBiologics
 MassBiologics BiotechnologyHealth Technology Part of University of Massachusetts, Inc., MassBiologics is a company that aims to improve public health by discovering and developing products. The company is based in Mattapan, MA. The company's focus is on creating products for smaller patient populations, uncertain markets, and developing nations with limited resources and unique needs. | Biotechnology | Chairman | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Human Resources Officer | |
| The University of Connecticut School of Medicine | College/University | Doctorate Degree | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| C4 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Greenleaf Health Inc.
 Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kinsale Holdings, Inc., Greenleaf Health Inc. is a leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. The company is based in Washington. Greenleaf is guided by experts with a combined total of more than 300 years of FDA experience, including former leaders throughout the agency. The American company was founded in 2007 by Patrick Ronan. Greenleaf Health was acquired by Kinsale Holdings, Inc. on April 19, 2021. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Virginia Center For Translational & Regulatory Sciences | Director/Board Member | ||
Olivo Laboratories LLC
 Olivo Laboratories LLC Medical/Nursing ServicesHealth Services Olivo Laboratories LLC provides solutions to skin-related medical problems through proprietary biomaterials technologies. Its platform technology consists of a tunable polysiloxane-based material that mimics youthful skin and can be engineered to provide a variety of targeted properties, including elasticity, breathability, invisibility, water resistance, protection. The company was founded by Robert S. Langer Jr. and Richard Rox Anderson and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director/Board Member | |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Chairman Director/Board Member Chairman Director/Board Member | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
Upstream Bio, Inc.
 Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Chairman Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Regno Unito | 3 |
| Canada | 2 |
| Irlanda | 2 |
| Israele | 2 |
Settori
| Health Technology | 26 |
| Finance | 9 |
| Consumer Services | 8 |
| Health Services | 3 |
| Government | 3 |
Posizioni
| Director/Board Member | 101 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 44 |
| Chairman | 29 |
| Undergraduate Degree | 17 |
Contatti più connessi
| Insiders | |
|---|---|
| Jean-Francois Formela | 47 |
| Daniel Lynch | 32 |
| Ronald Renaud | 24 |
| Owen Hughes | 23 |
| Robert Meyer | 13 |
| George Demetri | 12 |
| E. Sutherland | 12 |
| John R. Schroer | 12 |
| Daniella Beckman | 10 |
| Paul Burgess | 10 |
| Ann J. Barbier | 9 |
| Robert Plenge | 8 |
| Brian Fenton | 7 |
| James Sullivan | 7 |
| Richard Wooster | 6 |
- Borsa valori
- Insiders
- Greg Troiano
- Connessioni Società
